Frontier Wealth Management’s Edwards Lifesciences EW Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q2	$335K	Sell	3,524 -50	-1%	-$4.75K	0.02%	288
2022 Q1	$432K	Hold	3,574	–	–	0.01%	261
2021 Q4	$463K	Sell	3,574 -100	-3%	-$13K	0.03%	273
2021 Q3	$416K	Sell	3,674 -258	-7%	-$29.2K	0.03%	286
2021 Q2	$407K	Buy	3,932 +88	+2%	+$9.11K	0.03%	287
2021 Q1	$322K	Sell	3,844 -326	-8%	-$27.3K	0.02%	297
2020 Q4	$380K	Sell	4,170 -100	-2%	-$9.11K	0.03%	269
2020 Q3	$341K	Sell	4,270 -200	-4%	-$16K	0.03%	268
2020 Q2	$309K	Hold	4,470	–	–	0.03%	271
2020 Q1	$281K	Buy	+4,470	New	+$281K	0.05%	223
2019 Q4	–	Sell	-5,370	Closed	-$394K	–	308
2019 Q3	$394K	Sell	5,370 -150	-3%	-$11K	0.06%	215
2019 Q2	$340K	Hold	5,520	–	–	0.05%	228
2019 Q1	$352K	Sell	5,520 -1,800	-25%	-$115K	0.05%	254
2018 Q4	$374K	Hold	7,320	–	–	0.06%	237
2018 Q3	$425K	Hold	7,320	–	–	0.04%	250
2018 Q2	$355K	Hold	7,320	–	–	0.05%	265
2018 Q1	$340K	Hold	7,320	–	–	0.05%	283
2017 Q4	$275K	Sell	7,320 -3,300	-31%	-$124K	0.04%	280
2017 Q3	$387K	Hold	10,620	–	–	0.06%	264
2017 Q2	$419K	Buy	10,620 +600	+6%	+$23.7K	0.06%	253
2017 Q1	$314K	Buy	+10,020	New	+$314K	0.05%	295
2015 Q4	–	Sell	-14,976	Closed	-$355K	–	356
2015 Q3	$355K	Sell	14,976 -3,462	-19%	-$82.1K	0.06%	234
2015 Q2	$438K	Sell	18,438 -1,998	-10%	-$47.5K	0.07%	216
2015 Q1	$485K	Buy	20,436 +4,728	+30%	+$112K	0.08%	170
2014 Q4	$333K	Buy	+15,708	New	+$333K	0.06%	174